Healthcare utilization, mortality, and cardiovascular events following GLP1-RA initiation in chronic kidney disease by Shuyao Zhang, Fnu Sidra, Carlos A. Alvarez, Mustafa Kinaan, Ildiko Lingvay, Ishak A. Mansi

Get full text

Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses by Ildiko Lingvay, Emre Yildirim, Richard E Pratley, Vanita R Aroda, Andrei-Mircea Catarig, Jörg Lüdemann, Adie Viljoen

Get full text

Comparative Evaluation of Two Venous Sampling Techniques for the Assessment of Pancreatic Insulin and Zinc Release upon Glucose Challenge by Anil Kumar Pillai, William Silvers, Preston Christensen, Matthew Riegel, Beverley Adams-Huet, Ildiko Lingvay, Xiankai Sun, Orhan K. Öz

Get full text

Factors influencing the selection of an SGLT2i vs. a GLP-1RA as cardioprotective agent in patients with type 2 diabetes by Shubham Agarwal, Mujeeb A. Basit, Michael E. Bowen, Daniel F. Heitjan, Daniel F. Heitjan, Christine Mai, Kelsea Marble, Jonathan Pak, Zichang Xiang, Ildiko Lingvay

Get full text

Characteristics of patients prescribed SGLT-2i and/or GLP-1RA among cardiology clinics in the US: insights from the COORDINATE-diabetes trial by Adam J Nelson, Lisa A. Kaltenbach, Hussein R. Al-Khalidi, Monica Leyva, Laura Webb, Darren K. McGuire, Rodica Pop-Busui, Matthew A Cavender, Vanita R. Aroda, Melissa L. Magwire, Caroline R. Richardson, Ildiko Lingvay, Julienne K. Kirk, Ambarish Pandey, Tanya Gaynor, Jonathan Pak, Alana Washington, Cagri Senyucel, Renato D. Lopes, Jennifer B. Green, Christopher B. Granger, Neha J Pagidipati

Get full text